Moreover, reduced oxygen levels significantly increased inhibition of FGFR3-downstream signaling and improved the anticancer activity of both cobalt(iii) complexes against ABL- and FGFR-dependent human cancer cell models. The gene discussed is ABL1; the disease is cancer.